News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Razelle Kurzrock: Toll-like receptor 3 – a double-edged sword
Razelle Kurzrock/froedtert.com
Mar 31, 2025, 14:52

Razelle Kurzrock: Toll-like receptor 3 – a double-edged sword

Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a post on X:

“Many immunomodulators, including TLR3 and other toll like receptors, have dual inhibitory and stimulatory functions.

They are double-edged sword!”

“Toll-like receptor 3: a double-edged sword.”

Authors: Marvin L Hsieh, Daisuke Nishizaki, Jacob J Adashek, Shumei Kato and Razelle Kurzrock

Razelle Kurzrock

cancer Daisuke Nishizaki Jacob J. Adashek Marvin L Hsieh OncoDaily Oncology Razelle Kurzrock Shumei Kato TLR3
Special Coverage
Voices
Aug 10, 2025, 15:36
Wafaa M Rashed: Africa for Africans - Shaping the Future of Genomics Policy
Career
Aug 10, 2025, 15:36
Bogda Koczwara: Join the Team of Australian Research Centre for Cancer Survivorship
Voices
Aug 10, 2025, 15:26
Sendurai Mani: Joining the Partnership to Reduce Cancer in Rhode Island Membership Meeting
Career
Aug 10, 2025, 15:00
Santosh Rao Joined to the HemOnc Department at Cleveland Clinic Akron General as the Medical Director
Science
Aug 10, 2025, 14:54
Monika J Dziuba: The Role of Organoids in Precision Medicine
Voices
Aug 10, 2025, 14:50
The Future of Pharmaceutical Infrastructure and Equitable Access to Medicines - Hikma Pharmaceuticals
Voices
Aug 10, 2025, 14:31
Anju Aledia: Celebrating Strength, Unity, and Hope Among Children Fighting Cancer
Voices
Aug 10, 2025, 14:19
Harish Nagaraj: Advancing Neuroendocrine Tumor Care in East and Sub-Saharan Africa
Opinion
Aug 10, 2025, 13:44
Olivier Elemento: Accelerating Innovation with Safe and Effective Guardrails
Voices
Aug 10, 2025, 13:01
Olubukola Ayodele: Breast Cancer Subtypes and What They Mean for Patients and Treatment
Voices
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial
Blog
Aug 10, 2025, 12:46
Ashwin Mallya: Bladder Cancer Care is No Longer a Solo Act